Nine Ten Capital Management LLC
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 13, 2025), Nine Ten Capital Management LLC reported 11 stock positions worth $350.3 million. Its top holding was Cellebrite Di (CLBT) at 22.7% of the portfolio, followed by Iradimed (IRMD, 14.2%) and Magnite (MGNI, 14.2%). Compared with Q3 2024, it opened 1 new position, added to 4 and reduced 5. The biggest buy was a new position in Gpgi (GPGI) and the biggest sale Agilysys (AGYS, shares −37%).
- Most Recent 13F
- Q2 2026
- Location
- CHICAGO, IL
- CIK
- 0001635236
- Portfolio Value
- $350.3M (Q4 2024)
- SEC Filing
- 0001420506-25-000369 ↗ filed Feb 13, 2025
Holdings Value
Holdings 11 stocks · $350.3M
| CLBT Cellebrite Di Ltd. | 22.67% | 3,605,604 | $79.4M | Reduce -16.7% |
| IRMD Iradimed Corp. | 14.22% | 905,926 | $49.8M | No change |
| MGNI Magnite Inc. | 14.16% | 3,115,849 | $49.6M | Add +18.8% |
| SNEX Stonex Group Inc. | 10.89% | 389,491 | $38.2M | Reduce -17.2% |
| WINA Winmark Corp. | 9.41% | 83,900 | $33.0M | Add +5.5% |
| SPNS Sapiens International Corp. | 8.24% | 1,074,291 | $28.9M | Add +17.0% |
| AGYS Agilysys Inc. | 5.95% | 158,139 | $20.8M | Reduce -36.6% |
| FC Franklin Covey Co. | 4.49% | 418,166 | $15.7M | Reduce -8.7% |
| GPGI Gpgi Inc. filed as COMPOSECURE INC | 3.97% | 908,328 | $13.9M | New |
| NVEE NV5 Global Inc. | 3.82% | 709,852 | $13.4M | Add +0.6% |
| XPEL Xpel Inc. | 2.17% | 190,716 | $7.6M | Reduce -20.8% |
Portfolio Sells Q3 2024 → Q4 2024
Portfolio Buys Q3 2024 → Q4 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 8 | $321.3M | AGYS, MGNI, CLBT, GPGI, WINA |
| Q1 2026 | 8 | $314.8M | GPGI, CLBT, SNEX, AGYS, MGNI |
| Q4 2025 | 8 | $315.8M | MGNI, GPGI, CLBT, AGYS, IRMD |
| Q3 2025 | 9 | $388.0M | MGNI, IRMD, SPNS, CLBT, GPGI |
| Q2 2025 | 9 | $336.1M | MGNI, IRMD, AGYS, SNEX, CLBT |
| Q1 2025 | 11 | $267.9M | IRMD, SNEX, CLBT, MGNI, SPNS |
| Q4 2024 | 11 | $350.3M | CLBT, IRMD, MGNI, SNEX, WINA |
| Q3 2024 | 10 | $330.9M | CLBT, IRMD, SNEX, MGNI, SPNS |
| Q2 2024 | 10 | $259.8M | CLBT, IRMD, SNEX, AGYS, SPNS |
| Q1 2024 | 13 | $328.4M | SNEX, AGYS, MGNI, CLBT, IRMD |